Peptide vaccines usable for hypercholesterolemia related diseases
US-2024197844-A1 · Jun 20, 2024 · US
Insulin albumin conjugates
US9242011B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9242011-B2 |
| Application number | US-93543809-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 31, 2009 |
| Priority date | Apr 1, 2008 |
| Publication date | Jan 26, 2016 |
| Grant date | Jan 26, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Insulin albumin conjugates consisting of an insulin analogue, a bifunctional linker and albumin can efficiently be used to treat diabetic patients.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound of M-Z n —Y o -Ins or formula II: Alb-M′-Z n —Y o -Ins; formula III: wherein Ins represents insulin or a human insulin analogue; wherein the human insulin analogue has a lysine residue at the C-terminal end of the A-chain (A22K), or at the C-terminal end of an extension of the A-chain; wherein the extension, compared to the A21 amino acid residue, consists of a single amino acid residue being lysine, or a lysine residue at the C-te…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9242011B2 cover?
- Insulin albumin conjugates consisting of an insulin analogue, a bifunctional linker and albumin can efficiently be used to treat diabetic patients.
- Who is the assignee on this patent?
- Tagmose Tina Møller, Madsen Peter, Kjeldsen Thomas Børglum, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K47/643. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).